Associate Director, Oncology Clinical Intelligence and Real World Evidence

AstraZeneca•Cambridge, MA
•$144,649 - $216,973•Hybrid

About The Position

The Associate Director, Oncology Clinical Intelligence and Real World Evidence turns complex clinical and real-world data into evidence that informs pivotal decisions in Hematology/Oncology, including Phase 3 investments, trial design, and patient access. The role combines portfolio-level evidence prioritization with hands-on analytics, partnering with stakeholders to identify high-value evidence gaps and lead work that addresses them. As a technical specialist in clinical intelligence and real-world evidence, the role develops decision-ready insights and persistent intelligence across use cases. This includes building and validating multimodal patient models and external control arm analyses, and translating internal, competitor-trial, and real-world data into insights on standards of care, patient pathways, benchmarking, and unmet need. The role also works with platform and tooling teams to enable evidence-generation capabilities and collaborates across development, regulatory, access, Translational Science, and Clinical Development.

Requirements

  • PhD or equivalent advanced degree in a quantitative discipline such as epidemiology, biostatistics, computational biology, machine learning, health data science, or a related field.
  • Strong methodological foundation in causal inference and observational study design, including propensity score methods, instrumental variables, target trial emulation, and comparative effectiveness research.
  • Hands-on experience with machine learning and multimodal modeling, including supervised and unsupervised methods, deep learning for imaging or molecular data, and integration of heterogeneous data into patient-level models.
  • Experience building or contributing to external control arms, trial simulators, or prognostic models using real-world and/or clinical trial data.
  • Understanding of regulatory and health technology assessment (HTA) evidence standards and ability to design analyses that meet evidentiary requirements for submissions and payer engagement.
  • Proficiency in Python, R, and SQL.
  • Familiarity with cloud-based analytics environments.

Nice To Haves

  • Domain expertise in hematology or oncology and familiarity with disease-specific endpoints, pathways, and standards of care.
  • Track record of influencing cross-functional strategy with evidence and engaging product and clinical leaders to drive decisions.
  • Experience deploying analytics into clinical trial operations, submissions, or payer engagements.
  • Publications, conference presentations, or open-source contributions in causal inference, multimodal modeling, or real-world evidence.
  • Hands-on experience with cloud platforms and MLOps practices to scale models and pipelines.
  • Experience integrating digital endpoints, pathology AI, or biomarker panels into evidence strategies.
  • Ability to design reusable data and model assets that generalize across indications and studies.

Responsibilities

  • Partner with Hematology/Oncology stakeholders and Global Product Teams to identify and prioritize evidence needs throughout the product lifecycle, including Phase 3 investment decisions, subpopulation discovery, and trial design.
  • Apply machine learning and causal inference to patient stratification, external control arms, prognostic risk adjustment, and treatment-effect heterogeneity analyses, ensuring analyses meet regulatory and HTA expectations.
  • Deliver and validate patient-level models integrating clinical, genomic, imaging, and real-world data for use in clinical trials or routine care, with emphasis on reproducibility and rigorous validation.
  • Translate internal and competitor trial data, together with real-world data, into insights about standard of care, patient pathways, benchmarking, and unmet need to inform development and access strategies.
  • Work with platform and tooling teams to bring new tools, agents, and experimental approaches into evidence generation, and build Hematology-specific intelligence for the Phase 3 Investment Decision Intelligence Foundation.
  • Align technical delivery with strategic evidence needs and development, regulatory, and access milestones.
  • Collaborate with Translational Science and Clinical Development to incorporate signals such as digital endpoints, pathology AI, and biomarker panels.

Benefits

  • Short-term incentive bonus opportunity
  • Eligibility to participate in an equity-based long-term incentive program
  • Qualified retirement program (401(k) plan)
  • Paid vacation and holidays
  • Paid leaves
  • Medical, prescription drug, dental, and vision coverage

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume

What This Job Offers

Job Type

Full-time

Career Level

Director

Education Level

Ph.D. or professional degree

© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service